产品设计开发高级科学家(基因编辑)
2.2-2.7万·14薪
 南京-江宁区
 在校生/应届生
 博士
 全职
 招若干人
 更新于09-03
收藏
职位信息

Job Location: Nanjing, China
Responsibilities:
- Lead, design, and execute experiments aimed at developing next-generation genome editing strategies using CRISPR-based tools and beyond.
- Design and produce DNA, RNA, and virus-based reagents for genome editing experiments in human cells.
- Apply various genome editing tools at different stages of CAR-T discovery and development.
- Develop and execute in-house NGS workflows, including the following: NGS library preparation and quantification.
- Lead from the lab to advance novel and differentiated cell therapy products toward clinical milestones, by working collaboratively with internal cross-functional teams and external partners.
- Contribute creatively to seed innovation projects through literature review and shape execution tactics.
- Recommends changes to project direction based on an understanding of current literature and in-house experimental data.
- Accurately capture data in a timely manner, ensuring data integrity and protocol compliance.
Qualifications:
- PhD in molecular biology, biochemistry, synthetic biology or a related field.
- Extensive experience in the development and implementation of advanced genetic tools - such as genome editing, CRISPR systems, transposons and DNA assembly - with particular emphasis on the challenges associated with applying these tools in mammalian cells.
- Proficiency in standard molecular techniques, e.g., cloning strategies, PCR, library preparation for next generation sequencing, RNA handling, qPCR, etc.
- Experience with NGS library prep, characterization and optimization of CRISPR systems or other technologies.
- Good coordination and communication skills are required. Highly organized and efficient, able to work independently.
- Strong problem-solving skill is preferred. Ability to coordinate parallel tasks across multiple projects, demonstrating prioritization.
工作地址
 同方科技工业园南门
应届生安全提醒
求职过程中如果遇到违规收费、信息不实、以招聘名义的培训收费或者微信营销等虚假招聘行为,请保留证据,维护自己的合法权益。谨防上当受骗!
公司信息
关于传奇生物
传奇生物(NASDAQ:LEGN)成立于2014年,是一家集肿瘤免疫细胞疗法研发、临床、生产及商业化开发于一体的跨国生物制药公司,位列全球免疫细胞疗法领域第一方阵,全球员工总数逾1500人。目前通过与杨森的合作,首款产品CARVYKTI?(西达基奥仑赛,Cilta-cel)于2022年获得美国食品药品监督管理局(FDA)、日本厚生劳动省(MHLW)批准上市,并获得欧盟委员会(EC)附条件上市许可,有望解决多发性骨髓瘤治疗的世界级难题。2022年底,国家药品监督管理局已正式受理西达基奥仑赛的新药上市申请(NDA),并于2023年1月纳入优先审评程序。此外,公司还有多款在研细胞疗法,用于血液瘤、实体瘤及其它疑难疾病的治疗。
公司先后入选江苏省战略性新兴产业发展专项资金项目、“江苏省精准细胞免疫治疗工程技术研究中心”、“江苏省研究生工作站”、“江苏省隐形小巨人企业”、“南京市工程研究中心”,“南京市高端研发机构”、“南京市博士后创新实践基地”、“南京市独角兽企业”、“中国独角兽企业”,荣获“江苏省科技进步奖”、“中国生物医药产业链创新风云榜鲲鹏奖”、“中国医药创新企业100强”、“南京市引才用才示范企业金梧桐奖”、“《麻省科技评论》50家聪明公司”、“最具影响力创新疗法企业TOP20”、“中国医药高质量发展成果企业”等荣誉。
下载App 查看公司其他职位
公司信息更多职位
img南京传奇生物科技有限公司
外资(欧美)
制药/生物工程
有没有拿到笔面试邀请的同学呀?
有,上周人事联系说通过了
还是已提交,有别的进度的吗
会通知简历过了
事业单位上岸交流帖!
希望自己能过面试。
下载App 参与互动